Quviviq NHS guide
Quviviq (daridorexant) is recommended by NICE for long term insomnia, so in theory it is available on the NHS. In practice, many people are told no, wait, or try something else first. This guide explains how NHS access actually works, why it is patchy, and how to get Quviviq privately from a UK registered pharmacy with a price match guarantee if the NHS route is not open to you.
Yes, Quviviq can be prescribed on the NHS. NICE recommended daridorexant in technology appraisal TA922 for adults with long term insomnia, and the Scottish Medicines Consortium accepted it for NHS Scotland. Once NICE recommends a medicine, NHS organisations in England are expected to fund it for patients who meet the criteria.
The catch is in the criteria and in how local NHS areas apply them. To qualify you generally need:
That third point is where most people get stuck. If you have been through the NHS route and hit a wall, or you do not want to wait, The Care Pharmacy supplies Quviviq privately after an online consultation, with a price match guarantee against any other UK registered pharmacy. Treatment is prescription only and is never guaranteed.
Recommended by NICE, but access depends on your local area, your GP and whether you have completed CBT for insomnia first.
A UK prescriber reviews your consultation. If suitable, 30 tablets are dispensed by our GPhC registered pharmacy and delivered discreetly.
Whether NHS or private, Quviviq is the same licensed product and the same safety checks apply.
NICE technology appraisal TA922 recommends daridorexant as an option for treating long term insomnia in adults, but only if:
NICE also says treatment should be reviewed within three months of starting, and stopped if it is not working. That is not a barrier. It is good practice, and it is the same standard The Care Pharmacy applies to private patients.
Why did NICE approve it? Because daridorexant works differently from older sleeping tablets. Zopiclone and zolpidem sedate the brain and are licensed for short courses only, because of tolerance and dependence. Daridorexant blocks orexin, the chemical that keeps you awake, and was assessed as a long term option. Trials followed people for 12 months and did not show rebound insomnia or withdrawal on stopping.
A NICE recommendation opens the door. It does not put the medicine in your hand. Here is where people get stuck.
NICE positions CBT for insomnia as the first line treatment. Many GPs will want to see that you have tried it before prescribing daridorexant. NHS access to CBT for insomnia varies widely. Some areas offer digital programmes, some have long waits, some have very little. If you have not been offered it, you may be sent there first.
Integrated care boards publish their own guidance on new medicines. Some allow GPs to start daridorexant. Others restrict it to specialist initiation or ask for documented failure of other approaches. Your postcode can decide how easy this is.
Daridorexant is still a relatively new medicine in primary care. Some GPs prescribe it readily. Others are more cautious, or prefer to refer to a sleep clinic, which adds months.
Even when everything lines up, the route is often: GP appointment, sleep hygiene advice, referral for CBT for insomnia, wait, complete the programme, return to the GP, then discuss medicine. For someone who has not slept properly in a year, that is a long road.
None of this means you should give up on the NHS route. If you qualify, it is free apart from the prescription charge, and your GP knows your full history. It does mean you should know the alternative exists.
If you want to try the NHS route first, go prepared. It makes a real difference.
If your GP says no, ask why. If the answer is “you need to try CBT first” and the wait is long, or “we do not prescribe it here”, you have a clear picture and can decide what to do next.
If the NHS route is closed, slow or simply not right for you, you can get Quviviq privately without a GP appointment. This is not a shortcut around the safety checks. It is the same medicine, prescribed by a UK clinician, dispensed by a GPhC registered pharmacy.
Prescription treatment is not guaranteed. If Quviviq is not suitable, we will tell you why and talk through alternatives.
At The Care Pharmacy, Quviviq is currently £62.99 to £64.99 for a box of 30 tablets, which is one month of treatment. That is the whole cost. Consultation and clinical review are included. Delivery is free on orders over £40.
Price Match Guarantee. If you find Quviviq cheaper at another UK registered pharmacy, send us the link and we will match it. You will not pay more with us than anywhere else in the UK for the same medicine from a regulated source.
Why does that matter? Because private Quviviq prices vary between providers, and some sites add consultation fees, subscription terms or delivery charges on top of the headline figure. Compare the total, not the first number you see.
One more thing. If you are tempted by a site selling Quviviq without a consultation, or at a price that seems impossible, walk away. Quviviq is prescription only. Anyone supplying it without a prescriber review is either breaking the law or not selling the real thing. Check any seller on the MHRA authorised seller register and the GPhC register.
| NHS | The Care Pharmacy (private) | |
|---|---|---|
| The medicine | Quviviq 25mg or 50mg | Quviviq 25mg or 50mg, identical licensed product |
| Who prescribes | GP or sleep specialist, depending on local policy | UK registered prescriber after online consultation |
| Eligibility | NICE TA922 criteria, usually including CBT for insomnia first | Clinical suitability assessed against the licence and NICE guidance |
| Cost per month | NHS prescription charge, or free if exempt | £62.99 to £64.99, price matched |
| Time to treatment | Weeks to months, depending on CBT access and referrals | Consultation reviewed, then dispatched by tracked delivery if approved |
| Review | Within three months, per NICE | Within three months, per NICE |
The honest summary: if you qualify and your area prescribes it, the NHS is cheaper. If you are stuck in the queue, private supply gets you the same medicine with the same checks, at a known cost, without waiting.
Quviviq is licensed for adults whose insomnia has lasted at least three months and considerably affects daytime functioning. It may suit you if you:
Tell the prescriber if you have depression or a history of self harm thoughts, a history of drug or alcohol misuse, breathing problems such as severe COPD or sleep apnoea, or if you are over 65 with a history of falls. Do not drink alcohol while taking Quviviq, and do not drive until you know how it affects you.
Common side effects include headache, next day sleepiness, tiredness, dizziness and vivid dreams. Full safety information is on the Quviviq product page. Suspected side effects can be reported through the MHRA Yellow Card scheme.
Not sure whether your sleep problem is insomnia? Our insomnia test guide helps you work out the pattern before you start a consultation.
Yes. NICE recommends daridorexant for adults with long term insomnia where CBT for insomnia has not worked, is unavailable or is unsuitable. Access depends on your local area and your GP.
In many areas, yes, if you meet the NICE criteria. Some integrated care boards restrict it to specialist initiation. Ask your GP directly and mention NICE TA922.
The most common reasons are that CBT for insomnia has not been tried first, your symptoms have not lasted three months, or your local area has restrictions on who can prescribe it. Ask your GP which applies.
At The Care Pharmacy, £62.99 to £64.99 for 30 tablets, with consultation included and a price match guarantee against any other UK registered pharmacy. Prices are correct at the time of writing. Check the product page for the current figure.
Yes. It is the same licensed medicine made by Idorsia, in the same 25mg and 50mg strengths, supplied through the regulated UK pharmacy chain.
Our prescriber will ask what you have tried and will take NICE guidance into account. Having tried CBT for insomnia, or being unable to access it, is part of the assessment rather than an automatic bar.
Quviviq is not a benzodiazepine or Z drug. Clinical studies did not show dependence, tolerance, rebound insomnia or withdrawal symptoms. It is still a prescription medicine and treatment is reviewed regularly.
You do not have to. Complete a short consultation and our UK prescriber will tell you whether Quviviq is right for you. Same medicine, same safety checks, price matched against any UK registered pharmacy. Prescription treatment is never guaranteed.
Medically reviewed by
Superintendent Pharmacist
A safe UK insomnia test guide explaining sleep patterns, daytime impact, red flags and when to consider regulated assessment.
A UK guide to melatonin legality, prescription-only rules, over-the-counter availability and safe insomnia assessment routes.
A UK guide to melatonin tablets, prescription-only access, safety checks and when persistent insomnia needs assessment.
A UK guide to Nytol One-A-Night, diphenhydramine, side effects, short-term use and when insomnia needs assessment.
A UK guide to over-the-counter sleeping tablets, diphenhydramine, melatonin rules, pharmacy sleep aids and when insomnia needs assessment.
A UK guide to strong sleeping tablets, comparing prescription medicines, pharmacy sleep aids, melatonin, daridorexant and safe assessment routes.
